AAAAAA
Results:
1-7
|
Results: 7
Authors:
UDDIN S
SWEET M
COLAMONICI OR
KROLEWSKI JJ
PLATANIAS LC
Citation: S. Uddin et al., THE VAV PROTOONCOGENE PRODUCT (P95(VAV)) INTERACTS WITH THE TYK-2 PROTEIN-TYROSINE KINASE, FEBS letters, 403(1), 1997, pp. 31-34
Authors:
STACEY KJ
SWEET M
HUME DA
Citation: Kj. Stacey et al., ACTIVATION OF MACROPHAGES BY BACTERIAL-DNA, Journal of leukocyte biology, 1996, pp. 108-108
Authors:
SCHENKEIN DP
MILLER KB
SWEET M
ROSENBACH M
STADTMAUER E
CASSILETH P
COOPER B
LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL BOOD STEM-CELL (PBSC) TRANSPLANTATION AS INITIAL THERAPY FOR HIGH-RISK NON-HODSKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 86(10), 1995, pp. 3844-3844
Authors:
WECKSTEIN D
SPRAGUE K
HURLEY C
KARP D
BERKMAN E
CURTIN P
SCHENKEIN D
SWEET M
MILLER K
Citation: D. Weckstein et al., PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH GCSF PRIMED PERIPHERAL-BLOOD STEM-CELL RESCUE IN PATIENTS WITH ADVANCED CANCER, Blood, 86(10), 1995, pp. 3881-3881
Authors:
KOLSKY KL
JOSHI V
MEINKEN GE
SWEET M
MAUSNER LF
SRIVASTAVA SC
Citation: Kl. Kolsky et al., IMPROVED PRODUCTION, AND EVALUATION, OF CU-67 FOR TUMOR RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000259-160000259
Authors:
SCHENKEIN DP
MCCANN L
KANTETI R
BERKMAN E
ERBAN J
WECKSTEIN D
SWEET M
MILLER K
Citation: Dp. Schenkein et al., A RANDOMIZED TRIAL OF FILGRASTIM (G-CSF) PRIMED PERIPHERAL-BLOOD STEM-CELLS (PBSC) VS BONE-MARROW AS A RECONSTITUTION SOURCE FOR HIGH-DOSE CHEMOTHERAPY IN PATIENTS WITH LYMPHOMA AND HODGKINS-DISEASE - AN INTERIM CLINICAL AND MOLECULAR ANALYSIS, Blood, 84(10), 1994, pp. 10000204-10000204
Authors:
SWEET M
CROSS A
LEMAIRE C
ASHBY P
Citation: M. Sweet et al., MRI COMPLEMENTS EMG IN THE STUDY OF MUSCLE DENERVATION, Neurology, 43(4), 1993, pp. 322-322
Risultati:
1-7
|